Real-world safety of pre-exposure prophylaxis for HIV.
Publication
, Journal Article
Burns, CM; Wyatt, C
Published in: Lancet HIV
April 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet HIV
DOI
EISSN
2352-3018
Publication Date
April 2022
Volume
9
Issue
4
Start / End Page
e225 / e226
Location
Netherlands
Related Subject Headings
- Tenofovir
- Pre-Exposure Prophylaxis
- Humans
- HIV Infections
- Anti-HIV Agents
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Burns, C. M., & Wyatt, C. (2022). Real-world safety of pre-exposure prophylaxis for HIV. Lancet HIV, 9(4), e225–e226. https://doi.org/10.1016/S2352-3018(22)00058-3
Burns, Charles M., and Christina Wyatt. “Real-world safety of pre-exposure prophylaxis for HIV.” Lancet HIV 9, no. 4 (April 2022): e225–26. https://doi.org/10.1016/S2352-3018(22)00058-3.
Burns CM, Wyatt C. Real-world safety of pre-exposure prophylaxis for HIV. Lancet HIV. 2022 Apr;9(4):e225–6.
Burns, Charles M., and Christina Wyatt. “Real-world safety of pre-exposure prophylaxis for HIV.” Lancet HIV, vol. 9, no. 4, Apr. 2022, pp. e225–26. Pubmed, doi:10.1016/S2352-3018(22)00058-3.
Burns CM, Wyatt C. Real-world safety of pre-exposure prophylaxis for HIV. Lancet HIV. 2022 Apr;9(4):e225–e226.
Published In
Lancet HIV
DOI
EISSN
2352-3018
Publication Date
April 2022
Volume
9
Issue
4
Start / End Page
e225 / e226
Location
Netherlands
Related Subject Headings
- Tenofovir
- Pre-Exposure Prophylaxis
- Humans
- HIV Infections
- Anti-HIV Agents
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences